Should I Buy MLEC? MLEC 2026 Analysis

Should You Buy Moolec Science SA (MLEC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

5.390

1 Day change

-6.26%

52 Week Range

157.050

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: trend/momentum is still bearish and there are no Intellectia buy signals to override the setup.
Price (5.72) is below the pivot (6.362) with overhead resistance; upside needs confirmation before a chase makes sense.
Sentiment/data checks are mostly neutral (hedge funds/insiders/capitol), offering no strong supportive flow.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend: Bearish structure with SMA_200 > SMA_20 > SMA_5, signaling a downtrend across timeframes.
Momentum: MACD histogram -0.055 and negatively expanding → bearish momentum is strengthening.
RSI (6): 46.888 (neutral) → not oversold; lacks a strong mean-reversion “buy” trigger.
Key levels:
- Support: S1 5.158 (nearby), then S2 4.415.
- Resistance: Pivot 6.362 (first major hurdle), then R1 7.565.
Near-term pattern odds (similar candlesticks): ~80% chance of -0.68% next day, +1.96% next week, -1.38% next month → mixed, but not compelling for a “buy now” entry.

Positive Catalysts

- Revenue surged in the latest reported quarter (2025/Q2), showing strong top-line expansion.
- Current price is holding above nearby support (S1 5.158) after a strong regular-session move (+6.92%), which can attract short-term dip buyers.
- No negative news reported in the recent week (no fresh headline overhang).

Neutral/Negative Catalysts

- Bearish technical backdrop: downtrend moving averages + weakening MACD momentum.
- Pre-market -3.18% suggests the latest strength may be getting sold into.
- Profitability is weak: negative gross margin and continued net losses reduce fundamental support for rallies.
- No proprietary trading signals (AI Stock Picker/SwingMax) to justify an aggressive “buy now.”
- Broader tape is risk-off: S&P 500 -0.92% during the session context provided.

Financial Performance

Latest quarter: 2025/Q2
Revenue: 2,642,964, +948.32% YoY (strong growth).
Net Income: -2,427,307, improved +36.10% YoY but still negative.
EPS: -9.35, improved +32.06% YoY but still deeply negative.
Gross Margin: -25.78, down -133.20% YoY → margin deterioration is a key red flag despite revenue growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so no recent trend in Wall Street upgrades/downgrades can be confirmed.
Pros typically cited (based on provided fundamentals): explosive revenue growth.
Cons typically cited: persistent losses and negative/declining margins, which can keep institutional sponsorship limited.

Analyst Rating

Wall Street analysts forecast MLEC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MLEC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 5.750

Low

Averages

High